K. M. Hasan, A. Y. Elmeshhadany, and N. P. Shabila, “Evaluation of Ruxolitinib versus Best Available Therapy in Treating Primary Myelofibrosis”, Sultan Qaboos Univ Med J, vol. 22, no. 3, pp. 393–399, Aug. 2022.